Search results
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 20 hours agoVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 ...
Analyst Report: Vertex Pharmaceuticals Incorporated
Morningstar Research via Yahoo Finance· 17 hours agoIts key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. < ...
Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
GuruFocus.com via Yahoo Finance· 2 days agoIts primary products include Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for treating cystic...
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
Reuters· 2 days ago, opens new tab beat Wall Street estimates for first-quarter profit on Monday, driven by robust...
Inside The Outsole: The Science Of Trail Running Traction
Forbes· 1 day agoAll these traction questions require answers in the form of specific rubber compounds, lug designs...
Minoxidil vs. Rogaine: What's The Difference for Hair Growth?
MediaFeed via AOL· 3 days agoGrowing up, you may have longed for the new cool Nikes, but instead your parents got you the...
Biotech’s bind over China bill
Politico· 5 days agoThe proposal would establish a Medicare incentive payment program for hospitals and providers to use to entice supply-chain players like group purchasing organizations and wholesalers to meet ...
US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury...
Benzinga· 16 hours agoWall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of...
PeopleStrong, Google Cloud join hands to transform employee experience with AI
Investing.com· 2 days agoPeopleStrong, Google Cloud join hands to transform employee experience with AI
Morning Bid: Relief (mostly) everywhere
Reuters· 2 days agoThe relief across world markets as signs of a softening in the U.S. jobs markets strengthens the case for Federal Reserve rate cuts to start later this...
